Q: Is A-LIGN Vulnerability Assessment Service a good alternative to Rapid7 Nexpose?

A-LIGN Vulnerability Assessment Service and Rapid7 Nexpose serve similar Vulnerability Assessment use cases: both are Vulnerability Assessment tools. Review the feature comparison above to determine which fits your requirements.

Question 1

What is the difference between A-LIGN Vulnerability Assessment Service vs Rapid7 Nexpose?

Accepted Answer

**A-LIGN Vulnerability Assessment Service**: Vulnerability scanning service for network and application-level assessments. built by A-LIGN. Core capabilities include Network layer vulnerability scanning, Application level vulnerability scanning, Authenticated and unauthenticated scans..

**Rapid7 Nexpose**: On-premise vulnerability scanner with asset discovery and risk prioritization. built by Rapid7. Core capabilities include Real Risk Score with 1-1000 scale incorporating vulnerability age and exploit data, Adaptive Security for automatic detection and assessment of new devices, Policy assessment and benchmarking against CIS and NIST standards..

Both serve the Vulnerability Assessment market but differ in approach, feature depth, and target audience.

Question 2

What features do A-LIGN Vulnerability Assessment Service vs Rapid7 Nexpose offer?

Accepted Answer

**A-LIGN Vulnerability Assessment Service** differentiates with Network layer vulnerability scanning, Application level vulnerability scanning, Authenticated and unauthenticated scans. **Rapid7 Nexpose** differentiates with Real Risk Score with 1-1000 scale incorporating vulnerability age and exploit data, Adaptive Security for automatic detection and assessment of new devices, Policy assessment and benchmarking against CIS and NIST standards.

Question 3

Who makes A-LIGN Vulnerability Assessment Service vs Rapid7 Nexpose?

Accepted Answer

**A-LIGN Vulnerability Assessment Service** is developed by A-LIGN. **Rapid7 Nexpose** is developed by Rapid7. Vendor maturity, funding stage, and team size can be important factors when evaluating long-term viability and support quality.